Hyperbaric oxygen therapy for chronic wounds.

Area of Science:

• Wound healing research
• Hyperbaric medicine
• Clinical trial design

Background:

• Hyperbaric oxygen therapy (HBO) is considered an adjunctive treatment in wound care.
• Current evidence supporting HBO therapy is limited, particularly from randomized clinical trials.
• The efficacy of HBO for chronic wounds, especially non-diabetic ones, requires further investigation.

Purpose of the Study:

• To evaluate the current evidence base for hyperbaric oxygen therapy in wound management.
• To highlight the need for more rigorous clinical trials on HBO therapy.
• To determine the potential role of HBO in treating chronic wounds beyond diabetic foot ulcers.

Main Methods:

• Review of existing literature on hyperbaric oxygen therapy for wound healing.
• Analysis of the availability and quality of randomized clinical trials (RCTs) on HBO.
• Identification of research gaps in the application of HBO for various chronic wound types.

Main Results:

• A significant lack of high-quality randomized clinical trials investigating HBO therapy was identified.
• Existing studies may not provide sufficient evidence for widespread adoption in all wound care settings.
• The efficacy of HBO is primarily established for certain conditions, like diabetic wounds, with less data for others.

Conclusions:

• There is a critical need for more well-designed, randomized controlled studies to establish the efficacy of HBO therapy.
• Evidence-based practice guidelines for HBO in wound care require strengthening through further research.
• Future research should focus on diverse chronic wound populations to fully understand HBO's therapeutic potential.